Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy

Takako Inoue(Kaneka (United States)), Yasuhito Tanaka(Kumamoto University), Takaji Wakita(National Institute of Infectious Diseases), Hidenori Toyoda(Ogaki Municipal Hospital), Takashi Kumada(Gifu Kyoritsu University), Tatsuya Ide(Kurume University), Takuji Torimura(Omuta hospital), Akihito Tsubota(Jikei University School of Medicine), Su Su Hmwe(National Institute of Infectious Diseases), Koichi Takaguchi(Kagawa Prefectural Central Hospital), Keizo Kato(Gifu University), Noritomo Shimada(Otemae Hospital)
PLoS ONE
January 24, 2017
10.1371/journal.pone.0170667
Cited by 2

Related Papers

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
The lipid droplet is an important organelle for hepatitis C virus production
|Nature Cell Biology|2007|1.2k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
|Journal of Hepatology|2018|559